ArticleTrials2024

The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.

J Pedro Teixeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.